Elevated miR-200 boosts survival of lung, ovarian, renal, triple-negative breast canc

[News]

A family of microRNAs (miR-200) blocks cancer progression and metastasis by stifling a tumor's ability to weave new blood vessels to support itself, researchers at The University of Texas MD Anderson Cancer Center report today in Nature Communications.

More... (http://www.news-medical.net/news/20130912/Elevated-miR-200-boosts-survival-of-lung-ovarian-renal-triple-negative-breast-cancer-patients.aspx)